Akso Health Group (FRA:8HX)
Germany · Delayed Price · Currency is EUR 1.960
-0.020 (-1.01%)
At close: Mar 27, 2026
Akso Health Group Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 14.84 | 14.78 | 2.41 | 13.18 | 6 | - |
| 14.84 | 14.78 | 2.41 | 13.18 | 6 | - | |
Revenue Growth (YoY) | 75.55% | 512.09% | -81.68% | 119.69% | - | - |
Cost of Revenue | 14.69 | 15.06 | 2.29 | 11.91 | 5.39 | - |
Gross Profit | 0.15 | -0.28 | 0.12 | 1.27 | 0.61 | - |
Selling, General & Admin | 4.97 | 3.64 | 8.76 | 15.54 | 2.67 | 2.03 |
Operating Expenses | 4.97 | 3.64 | 8.76 | 15.54 | 3.06 | 2.09 |
Operating Income | -4.82 | -3.92 | -8.64 | -14.27 | -2.46 | -2.09 |
Interest Expense | - | - | - | - | -0.8 | -2.15 |
Currency Exchange Gain (Loss) | -0 | -0 | -0.59 | 1.14 | -0.75 | - |
Other Non Operating Income (Expenses) | 0 | 0.03 | 0.14 | 0.06 | 0 | -0.05 |
EBT Excluding Unusual Items | -4.81 | -3.89 | -9.09 | -13.07 | -4.01 | -4.29 |
Impairment of Goodwill | -41.37 | -41.37 | - | - | - | - |
Asset Writedown | -121.01 | -121.01 | - | - | - | - |
Pretax Income | -167.2 | -166.27 | -9.09 | -13.07 | -4.01 | -4.29 |
Income Tax Expense | -30.98 | -30.8 | 0.02 | 0.02 | 0.09 | - |
Earnings From Continuing Operations | -136.22 | -135.47 | -9.12 | -13.08 | -4.1 | -4.29 |
Earnings From Discontinued Operations | - | - | -0.4 | 11.84 | -12.75 | -30.53 |
Net Income to Company | -136.22 | -135.47 | -9.52 | -1.25 | -16.85 | -34.83 |
Minority Interest in Earnings | 0.55 | 0.49 | 0.06 | -0.11 | -0 | - |
Net Income | -135.67 | -134.98 | -9.46 | -1.36 | -16.85 | -34.83 |
Net Income to Common | -135.67 | -134.98 | -9.46 | -1.36 | -16.85 | -34.83 |
Shares Outstanding (Basic) | 463 | 285 | 47 | 23 | 20 | 16 |
Shares Outstanding (Diluted) | 463 | 285 | 47 | 23 | 20 | 16 |
Shares Change (YoY) | 204.20% | 504.37% | 106.30% | 15.07% | 22.06% | 0.17% |
EPS (Basic) | -0.29 | -0.47 | -0.20 | -0.06 | -0.85 | -2.14 |
EPS (Diluted) | -0.30 | -0.48 | -0.22 | -0.08 | -0.85 | -2.15 |
Free Cash Flow | -168.43 | 1.02 | 1.35 | -3.25 | -8.63 | 10.06 |
Free Cash Flow Per Share | -0.36 | 0.00 | 0.03 | -0.14 | -0.43 | 0.62 |
Gross Margin | 1.00% | -1.91% | 5.06% | 9.63% | 10.09% | - |
Operating Margin | -32.47% | -26.55% | -357.78% | -108.23% | -40.94% | - |
Profit Margin | -914.06% | -913.38% | -391.77% | -10.32% | -280.85% | - |
Free Cash Flow Margin | -1134.83% | 6.92% | 55.97% | -24.68% | -143.81% | - |
EBITDA | -1.46 | -1.77 | - | -14.25 | -2.44 | -2.07 |
EBITDA Margin | -9.85% | -12.00% | - | -108.09% | -40.63% | - |
D&A For EBITDA | 3.36 | 2.15 | - | 0.02 | 0.02 | 0.02 |
EBIT | -4.82 | -3.92 | -8.64 | -14.27 | -2.46 | -2.09 |
EBIT Margin | -32.47% | -26.55% | - | -108.23% | -40.94% | - |
Revenue as Reported | 14.84 | 14.78 | 2.41 | 13.18 | 6 | - |
Advertising Expenses | - | - | 0.17 | 0.01 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.